sinc
first
evid
regard
direct
transmiss
highli
pathogen
avian
influenza
viru
hpai
subtyp
poultri
human
result
death
infect
individu
hpai
becom
one
import
public
health
concern
worldwid
present
viru
spread
mani
countri
europ
asia
africa
identifi
fatal
influenza
infect
human
report
januari
increas
geograph
distribut
continu
evolut
virus
well
immunolog
human
popul
maintain
pandem
potenti
virus
addit
vaccin
administr
antivir
drug
virus
develop
effect
detect
approach
requir
manag
control
deadli
diseas
phage
display
recent
develop
technolog
phage
random
peptid
librari
consist
pool
billion
heterolog
peptid
produc
fusion
random
nucleic
acid
sequenc
n
terminu
one
capsid
protein
gene
filament
bacteriophag
phage
display
peptid
librari
power
tool
identifi
specif
ligand
target
protein
biopan
process
technolog
appli
success
numer
aspect
includ
antibodi
engin
peptid
protein
drug
discoveri
manufactur
diagnost
analysi
vaccin
develop
herein
identifi
three
phage
clone
specif
bind
hapi
virus
use
random
phage
librari
bind
peptid
phage
sequenc
importantli
identifi
phage
abl
distinguish
hapi
avian
virus
madindarbi
canin
kidney
mdck
cell
atcc
manassa
va
grown
dulbecco
mem
mm
lglutamin
fetal
bovin
serum
air
hpai
strain
propag
mdck
cell
absenc
serum
purifi
differenti
centrifug
convent
concentr
purifi
virus
dilut
pb
measur
thermo
scientif
nanodrop
spectrophotomet
nanodrop
technolog
thermo
fisher
scientif
wilmington
de
calcul
molar
absorb
coeffici
accord
manufactur
instruct
phage
display
done
accord
manufactur
instruct
new
england
biolab
minor
modif
first
round
pan
plate
coat
virus
concentr
ph
buffer
overnight
next
day
plate
block
h
skim
milk
dilut
volvol
tween
phosphatebuff
salin
pbst
follow
six
wash
tbst
mm
trishcl
ph
mm
nacl
volvol
tween
virus
incub
phage
librari
final
concentr
room
temperatur
min
gentli
rock
subsequ
unbound
phage
remov
time
wash
tbst
bound
phage
elut
ad
elut
buffer
glycinehcl
ph
room
temperatur
min
eluat
neutral
trishcl
ph
collect
titter
phage
amplifi
escherichia
coli
purifi
polyethylen
glycol
precipit
second
third
round
pan
repeat
similar
pan
condit
addit
increas
concentr
tween
volvol
tbst
fourth
round
pan
coat
virus
replac
supernat
form
mdck
cultur
incub
phage
supernat
room
temperatur
min
result
phage
subject
fifth
round
pan
titer
phage
input
elut
buffer
output
amplif
ecoli
determin
evalu
enrich
effici
posit
phage
clone
identifi
indirect
elisa
briefli
elisa
plate
coat
virus
dilut
concentr
seven
control
set
phage
librari
coat
group
phagefre
group
secondari
antibodyfre
group
porcin
transmiss
gastroenter
viru
coat
group
avian
infecti
bronchiti
viru
coat
group
block
buffer
group
viru
dilut
solut
coat
group
coat
process
done
overnight
next
day
plate
block
bovin
serum
albumin
bsa
tb
buffer
tbsb
h
room
temperatur
plate
wash
six
time
tbst
incub
individu
phage
last
round
biopan
concentr
ph
h
six
wash
tbst
polyclon
antibodi
dilut
tbsb
abcam
ad
well
h
six
wash
tbst
well
incub
horseradish
peroxidas
hrp
conjug
antirabbit
igg
antibodi
dilut
tbsb
sigma
color
develop
use
ophenylenediamin
opd
optic
densiti
od
valu
read
use
elisa
plate
reader
wavelength
nm
experi
perform
triplic
ten
posit
phage
clone
amplifi
precipit
polyethylen
glycolnacl
phage
clone
dna
purifi
use
plasmid
extract
kit
qiagen
germani
purifi
dna
templat
sens
primer
antisens
primer
use
pcr
amplifi
gene
encod
exogen
peptid
pcr
profil
includ
min
cycl
final
extens
min
correspond
amino
acid
sequenc
deduc
base
subsequ
dna
sequenc
sensit
detect
compar
antibodybas
elisa
revers
transcript
rt
pcr
determin
minimum
quantiti
viru
detect
phagebas
elisa
virus
serial
dilut
dmem
coat
elisa
plate
overnight
next
day
well
block
skim
milk
h
room
temperatur
select
phage
phage
complex
phage
display
librari
control
phage
dilut
pb
final
concentr
use
primari
antibodi
tripl
wash
tbst
well
incub
antibodi
dilut
pb
h
follow
anoth
incub
hrpconjug
goat
antirabbit
antibodi
dilut
pb
h
valu
detect
phage
well
p
neg
control
n
judg
posit
result
convent
elisa
virus
serial
dilut
dmem
medium
coat
elisa
plate
rabbit
antiserum
virus
serial
dilut
pb
buffer
incub
coat
virus
h
tripl
wash
tbst
well
incub
hrpconjug
secondari
antibodi
dilut
pb
anoth
h
normal
rabbit
serum
use
neg
control
elisa
detect
well
p
control
well
n
judg
posit
result
convent
rtpcr
amplifi
partial
hemagglutinin
ha
gene
bp
length
viru
perform
virus
dilut
pb
buffer
final
concentr
virus
adjust
mgml
firstli
ml
virus
subject
viral
rna
extract
use
rna
extract
kit
fastgen
china
accord
manufactur
instruct
extract
viral
rna
dissolv
diethyl
procarbon
treat
steril
water
volum
revers
transcript
system
includ
viral
rna
steril
water
mmlv
revers
transcriptas
takara
china
rnase
inhibitor
uml
oligo
dt
dntp
mixtur
mm
buffer
reaction
perform
min
min
min
result
cdna
serial
dilut
subject
pcr
pcr
mixtur
includ
cdna
taq
polymeras
keygen
china
dntp
mixtur
mm
buffer
sens
primer
antisens
primer
steril
water
pcr
paramet
compos
min
cycl
follow
min
authent
pcr
product
confirm
sequenc
specif
select
phage
evalu
use
diagnost
reagent
detect
panel
avian
virus
virus
includ
duck
plagu
viru
dpv
vaccin
strain
avian
bronchiti
viru
ibv
strain
beaudett
fowlpox
viru
fpv
isol
avian
infecti
bursal
diseas
viru
ibdv
strain
avian
infecti
laryngotrach
viru
ailv
strain
newcastl
diseas
viru
ndv
strain
la
sota
virus
dilut
final
concentr
coat
onto
elisa
plate
overnight
subsequ
elisa
step
perform
abovement
protocol
valu
record
least
three
independ
experi
carri
data
point
present
mean
sd
statist
signific
evalu
use
ttest
mean
valu
p
consid
statist
highli
signific
furthermor
identifi
phage
use
detect
avian
influenza
viru
coat
elisa
plate
analyz
specif
phagebas
elisa
use
abovement
procedur
present
antivir
drug
avail
fight
influenza
inhibitor
neuraminidas
inhibitor
nonetheless
emerg
drug
resist
influenza
strain
rais
concern
effect
report
inhibitor
resist
virus
widespread
efficaci
neuraminidas
inhibitor
oseltamivir
appear
time
depend
treatment
start
later
hour
post
infect
much
less
effect
therefor
altern
antivir
drug
requir
fight
influenza
vaccin
well
known
influenza
virus
dynam
continu
evolv
influenza
type
virus
undergo
antigen
drift
antigen
shift
result
new
viru
strain
may
recogn
antibodi
earlier
influenza
strain
therefor
ration
design
vaccin
influenza
vaccin
still
long
way
go
although
difficulti
tackl
influenza
viru
drug
vaccin
use
prevent
therapi
influenza
time
effect
diagnost
test
virus
screen
prior
applic
drug
vaccin
wide
accept
due
simplic
rapid
applic
one
purpos
current
studi
use
phage
display
identifi
specif
ligand
virus
report
regard
phagedisplay
peptid
select
combinatori
librari
interact
hepat
b
viru
adenoviru
type
and
viru
sin
nombr
viru
hantaan
viru
coronaviru
present
phage
display
technolog
becom
increasingli
attract
molecular
tool
research
biotechnolog
relat
field
studi
use
virion
immobil
target
perform
biopan
use
phage
display
peptid
librari
sinc
virus
harvest
cell
therefor
made
subtract
pan
includ
cell
supernat
target
incub
select
phage
decreas
reaction
background
addit
decreas
concentr
virus
gradual
improv
specif
identifi
phage
result
show
titer
elut
phage
increas
last
round
pan
data
shown
use
elisa
ten
phage
clone
specif
bind
virus
identifi
posit
result
found
control
confirm
bind
specif
phage
virus
figur
follow
extract
dna
select
phage
gene
encod
peptid
express
surfac
recombin
phage
amplifi
pcr
pcr
product
approx
bp
size
expect
figur
dna
sequenc
indic
among
select
phage
three
deduc
peptid
sequenc
amino
acid
length
identifi
tabl
phage
bear
peptid
hawdpipardpf
aawhlivalapn
atshlhvrlpsk
name
phage
respect
sequenc
data
deposit
genbank
databas
access
number
phage
respect
sever
put
motif
awxxi
rxpx
atshl
peptid
determin
role
identifi
peptidesmotif
viru
infect
need
investig
futur
recent
sialylgalactosebind
peptid
select
phage
librari
develop
novel
drug
interfer
interact
hemagglutinin
ha
influenza
viru
glycoconjug
receptor
cell
use
viral
hemagglutinin
protein
target
phage
display
technolog
recombin
fab
monoclon
antibodi
specif
ha
viru
also
character
nonetheless
knowledg
first
time
report
peptid
sequenc
bind
hpai
virus
experi
need
analyz
function
peptidesmotif
context
infect
sensit
phagebas
detect
firstli
analyz
elisa
shown
figur
minimum
quantiti
virus
phage
respect
phage
sensit
reagent
use
phagebas
elisa
use
viru
serum
primari
antibodi
analyz
sensit
antibodymedi
elisa
minimum
quantiti
virus
requir
elisa
determin
pn
valu
figur
addit
use
rtpcr
amplifi
partial
ha
gene
virus
use
mg
virus
extract
rna
rna
subject
revers
transcript
result
cdna
serial
dilut
use
templat
pcr
shown
figur
dilut
pcr
amplif
partial
ha
gene
posit
minimum
quantiti
virus
rtpcr
calcul
accord
equat
result
indic
phagebas
elisa
good
better
antiserumbas
elisa
rtpcr
detect
virus
sinc
anoth
purpos
studi
develop
novel
diagnost
assay
virus
clearli
import
abl
distinguish
influenza
viru
virus
might
caus
mix
infect
therefor
select
phage
analyz
specif
recogn
virus
avian
virus
avian
virus
select
studi
common
china
may
caus
coinfect
virus
shown
figur
three
identifi
phage
capabl
recogn
virus
specif
rather
control
virus
p
time
low
reactiv
control
phage
complex
phage
librari
target
elisa
exclud
artifact
clearli
analyz
specif
phagebas
elisa
includ
avian
influenza
virus
coat
antigen
phagebas
elisa
indic
three
phage
recogn
virus
lower
reaction
virus
compar
figur
p
test
strain
influenza
viru
even
influenza
speci
b
c
may
help
full
evalu
diagnost
applic
specif
assay
propag
phage
rel
cheap
done
larg
scale
therefor
specif
phage
identifi
studi
use
specif
inexpens
diagnost
reagent
detect
virus
diagnost
test
virus
realtim
rtpcr
genom
microarray
assay
report
recent
futur
would
interest
use
phage
detect
strain
influenza
virus
perform
actual
detect
viru
infect
sampl
